The owner of the Cesar pet food chain says his company is making “good progress” in the fight against Cesar’s flu pandemic, which has killed more than 60,000 people and forced millions to abandon homes.

Speaking at the company’s annual shareholders meeting in Dublin on Thursday, John McAfee, Cesar founder and chief executive, said that Cesar was making progress in its fight against the H1N1 virus and that it was a “perfect storm” for a “great” new product.

“The H1S1 virus is killing millions of people and we are making good progress,” McAfee said, adding that the company was “proud to be a leader” in a number of areas.

“We will have a great product that we’re working on,” he said.

The H2N1 pandemic killed nearly 2 million people and is currently being blamed on human error, not on Cesar.

A key challenge is developing an effective vaccine that can be given to people with flu symptoms and has yet to be tested on human volunteers, McAfee told the Irish Times.

He said that the Cepheid product was “a product that is being used on a commercial scale in the United States, in Europe and in other countries”.

“It is not a product we would like to introduce to consumers, but it’s not a question of if, but when,” he added.

Cesar is a leading pet food retailer and was one of the first to start selling Cepheids, a product that contains a fungus and other natural ingredients that can help fight H1Ns.

The company, which is based in the US, said it had not received any official complaints about the product and that its customers were “well informed about the benefits of Cepheirol and its other products”.

“We are not aware of any concerns from any of our customers or the public regarding the Cephia product,” a spokeswoman said.

McAfee said the company had been “working to build a strong relationship” with US regulators and that he would be “happy to work with any regulator in the country who wants to help”.

The company’s US arm is planning to expand its operations and McAfee’s comments are likely to raise eyebrows in Ireland, where Cephea’s US-based owner, A&C Laboratories, said in April that it would start using Cephelene as a feed additive in food products by the end of next year.

In the US state of Florida, where McAfee was also born, a similar product called Cephene has also been tested on pigs, but that has yet a firm launch date.

Cepheria, a type of fungus that grows on plant leaves, is a popular pet food ingredient.

In Ireland, the product is available only to Cephaleas customers.

McAucoin said he was not concerned about the introduction of the product in the Irish market.

“It’s going to be OK,” he told the paper.

“People will go out and buy Cephenes in supermarkets and restaurants.”

“It’ll be a little bit more expensive, but the same as Cepheras, it’s a great alternative,” he explained.

“I’m just looking forward to that.”